Piedmont Investment Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Piedmont Investment Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-25,962	Closed	-$278K	–	1310
2019 Q1	$278K	Buy	25,962 +1,806	+7%	+$19.3K	0.01%	856
2018 Q4	$211K	Buy	24,156 +1,355	+6%	+$17.3K	0.01%	913
2018 Q3	$383K	Buy	22,801 +885	+4%	+$19.2K	0.02%	656
2018 Q2	$459K	Buy	21,916 +2,552	+13%	+$47.3K	0.02%	465
2018 Q1	$312K	Buy	19,364 +743	+4%	+$14.7K	0.01%	553
2017 Q4	$353K	Buy	18,621 +2,055	+12%	+$37.2K	0.01%	511
2017 Q3	$233K	Buy	16,566 +1,266	+8%	+$11.5K	0.01%	671
2017 Q2	$114K	Buy	+15,300	New	+$100K	﹤0.01%	740

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Piedmont Investment Advisors's SPPI Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2019, closing a stake of 25,962 shares — an estimated $278K sold.

Piedmont Investment Advisors first reported a position in SPPI in Q2 2017 and held it in 8 quarters. The position peaked at $459K in Q2 2018. 165 funds tracked by Wall St. Rank hold SPPI as of Q2 2019.

Piedmont Investment Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
Piedmont Investment Advisors sold 25,962 Spectrum Pharmaceuticals Inc shares in Q2 2019, an estimated $278K.
Piedmont Investment Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2017 and held it in 8 quarters.
Piedmont Investment Advisors's Spectrum Pharmaceuticals Inc position peaked at $459K in Q2 2018.
165 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.